Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
0.00
-0.2010 (-2.11%)
Apr 29, 2026, 9:31 AM EDT - Market open
Upstream Bio Market Cap
Upstream Bio has a market cap or net worth of $517.53 million as of April 29, 2026. Its market cap has increased by 30.91% in one year.
Market Cap
517.53M
Enterprise Value
177.29M
1-Year Change
30.91%
Ranking
Category
Stock Price
n/a
Market Cap Chart
Since the IPO on October 11, 2024, Upstream Bio's market cap has increased from $393.35M to $517.53M, an increase of 31.57%. That is a compound annual growth rate of 19.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 517.53M | -64.73% |
| Dec 31, 2025 | 1.47B | 66.51% |
| Dec 31, 2024 | 881.13M | 124.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Altimmune | 532.11M |
| Kyverna Therapeutics | 526.61M |
| AgomAb Therapeutics NV | 518.56M |
| Tectonic Therapeutic | 510.72M |
| MiMedx Group | 505.13M |
| Zura Bio | 502.87M |
| Lyell Immunopharma | 500.98M |
| Fulcrum Therapeutics | 495.75M |